DSCC1
gene geneOn this page
Also known as DCC1hDCC1MGC5528
Summary
DSCC1 (DNA replication and sister chromatid cohesion 1, HGNC:24453) is a protein-coding gene on chromosome 8q24.12, encoding Sister chromatid cohesion protein DCC1 (Q9BVC3). Loads PCNA onto primed templates regulating velocity, spacing and restart activity of replication forks. It is a selective cancer dependency (DepMap: 21.7% of cell lines).
CHTF18 (MIM 613201), CHTF8 (MIM 613202), and DSCC1 are components of an alternative replication factor C (RFC) (see MIM 600404) complex that loads PCNA (MIM 176740) onto DNA during S phase of the cell cycle (Merkle et al., 2003 [PubMed 12766176]; Bermudez et al., 2003 [PubMed 12930902]).
Source: NCBI Gene 79075 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 62 total
- Cancer dependency (DepMap): dependent in 21.7% of screened cell lines
- MANE Select transcript:
NM_024094
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24453 |
| Approved symbol | DSCC1 |
| Name | DNA replication and sister chromatid cohesion 1 |
| Location | 8q24.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DCC1, hDCC1, MGC5528 |
| Ensembl gene | ENSG00000136982 |
| Ensembl biotype | protein_coding |
| OMIM | 613203 |
| Entrez | 79075 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 9 protein_coding, 1 retained_intron
ENST00000313655, ENST00000521795, ENST00000876772, ENST00000876773, ENST00000876774, ENST00000937369, ENST00000937370, ENST00000937371, ENST00000937372, ENST00000937373
RefSeq mRNA: 1 — MANE Select: NM_024094
NM_024094
CCDS: CCDS6330
Canonical transcript exons
ENST00000313655 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000926298 | 119838259 | 119838407 |
| ENSE00001290481 | 119833976 | 119835001 |
| ENSE00001296944 | 119853047 | 119853215 |
| ENSE00001298424 | 119842776 | 119842828 |
| ENSE00001306899 | 119841794 | 119841948 |
| ENSE00001313915 | 119850382 | 119850516 |
| ENSE00001315304 | 119855614 | 119855894 |
| ENSE00001318216 | 119843609 | 119843747 |
| ENSE00001321043 | 119846990 | 119847080 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 93.65.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.4627 / max 326.9004, expressed in 1512 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 94628 | 12.4627 | 1512 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 93.65 | gold quality |
| oocyte | CL:0000023 | 92.62 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.57 | gold quality |
| parotid gland | UBERON:0001831 | 85.40 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.75 | gold quality |
| buccal mucosa cell | CL:0002336 | 82.30 | silver quality |
| cortical plate | UBERON:0005343 | 81.65 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 81.39 | silver quality |
| ventricular zone | UBERON:0003053 | 81.22 | gold quality |
| embryo | UBERON:0000922 | 80.96 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.58 | gold quality |
| hair follicle | UBERON:0002073 | 77.88 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 77.10 | silver quality |
| trabecular bone tissue | UBERON:0002483 | 76.98 | gold quality |
| tibia | UBERON:0000979 | 76.59 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.41 | gold quality |
| squamous epithelium | UBERON:0006914 | 76.37 | gold quality |
| tendon | UBERON:0000043 | 76.15 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 75.61 | gold quality |
| bone marrow | UBERON:0002371 | 75.54 | gold quality |
| oviduct epithelium | UBERON:0004804 | 75.20 | silver quality |
| thymus | UBERON:0002370 | 74.84 | gold quality |
| visceral pleura | UBERON:0002401 | 74.30 | gold quality |
| gingival epithelium | UBERON:0001949 | 74.23 | gold quality |
| cerebellar vermis | UBERON:0004720 | 73.61 | silver quality |
| parietal pleura | UBERON:0002400 | 73.44 | gold quality |
| rectum | UBERON:0001052 | 73.42 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.41 | gold quality |
| lymph node | UBERON:0000029 | 73.02 | gold quality |
| pleura | UBERON:0000977 | 72.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.19 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F1
miRNA regulators (miRDB)
60 targeting DSCC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 21.7% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 6)
- hCTF18, hCTF8, and hDCC1 interact with each other as well as with the p38 subunit of RFC (PMID:12766176)
- The alternative Ctf18-Dcc1-Ctf8-replication factor C complex required for sister chromatid cohesion loads proliferating cell nuclear antigen onto DNA. (PMID:12930902)
- Stable interaction between the human proliferating cell nuclear antigen loader complex Ctf18-replication factor C (RFC) and DNA polymerase {epsilon} is mediated by the cohesion-specific subunits, Ctf18, Dcc1, and Ctf8. (PMID:20826785)
- E2F-dependent expression of DSCC1 confers anti-apoptotic properties in colorectal cancer cells. (PMID:24465681)
- DNA replication and sister chromatid cohesion 1 promotes breast carcinoma progression by modulating the Wnt/beta-catenin signaling and p53 protein. (PMID:33184243)
- Characterization of the prognostic, diagnostic, and immunological roles of DSCC1 and its genomic alteration and instability in human cancers. (PMID:38678604)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dscc1 | ENSDARG00000019907 |
| mus_musculus | Dscc1 | ENSMUSG00000022422 |
| rattus_norvegicus | Dscc1 | ENSRNOG00000026502 |
| drosophila_melanogaster | CG11788 | FBGN0034495 |
| caenorhabditis_elegans | dscc-1 | WBGENE00019595 |
Protein
Protein identifiers
Sister chromatid cohesion protein DCC1 — Q9BVC3 (reviewed: Q9BVC3)
Alternative names: Defective in sister chromatid cohesion protein 1 homolog
All UniProt accessions (1): Q9BVC3
UniProt curated annotations — full annotation on UniProt →
Function. Loads PCNA onto primed templates regulating velocity, spacing and restart activity of replication forks. May couple DNA replication to sister chromatid cohesion through regulation of the acetylation of the cohesin subunit SMC3.
Subunit / interactions. Component of the CTF18-RFC complex which consists of CTF8, CTF18, DSCC1 and the RFC complex. Interacts with CTF8 and CTF18. Interacts with DDX11.
Subcellular location. Nucleus.
Similarity. Belongs to the DCC1 family.
RefSeq proteins (1): NP_076999* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019128 | Dcc1 | Family |
Pfam: PF09724
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BVC3-F1 | 92.01 | 0.77 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-174411 | Polymerase switching on the C-strand of the telomere |
MSigDB gene sets: 200 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, GOBP_CHROMOSOME_ORGANIZATION, KANG_DOXORUBICIN_RESISTANCE_UP, GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS, FISCHER_G1_S_CELL_CYCLE, MODULE_545, GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY, MUELLER_PLURINET, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, GOBP_PROTEIN_ACETYLATION
GO Biological Process (6): DNA replication (GO:0006260), regulation of DNA replication (GO:0006275), maintenance of mitotic sister chromatid cohesion (GO:0034088), post-translational protein acetylation (GO:0034421), positive regulation of DNA-directed DNA polymerase activity (GO:1900264), mitotic sister chromatid cohesion (GO:0007064)
GO Molecular Function (4): DNA binding (GO:0003677), DNA clamp loader activity (GO:0003689), protein binding (GO:0005515), single-stranded DNA helicase activity (GO:0017116)
GO Cellular Component (5): chromosome, centromeric region (GO:0000775), chromatin (GO:0000785), nucleoplasm (GO:0005654), Ctf18 RFC-like complex (GO:0031390), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Telomere C-strand (Lagging Strand) Synthesis | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromosome | 2 |
| cellular anatomical structure | 2 |
| DNA metabolic process | 1 |
| DNA biosynthetic process | 1 |
| DNA replication | 1 |
| regulation of DNA metabolic process | 1 |
| mitotic sister chromatid cohesion | 1 |
| maintenance of sister chromatid cohesion | 1 |
| protein acetylation | 1 |
| post-translational protein modification | 1 |
| DNA-directed DNA polymerase activity | 1 |
| positive regulation of catalytic activity | 1 |
| regulation of transferase activity | 1 |
| positive regulation of DNA biosynthetic process | 1 |
| sister chromatid cohesion | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| ATP-dependent activity, acting on DNA | 1 |
| binding | 1 |
| DNA helicase activity | 1 |
| chromosomal region | 1 |
| nuclear lumen | 1 |
| nuclear protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1716 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DSCC1 | CHTF18 | Q8WVB6 | 999 |
| DSCC1 | CHTF8 | P0CG13 | 999 |
| DSCC1 | RFC2 | P32846 | 985 |
| DSCC1 | RFC5 | P40937 | 980 |
| DSCC1 | RFC3 | P40938 | 962 |
| DSCC1 | RFC4 | P35249 | 906 |
| DSCC1 | SMC3 | Q9UQE7 | 891 |
| DSCC1 | ESCO1 | Q5FWF5 | 858 |
| DSCC1 | WAPL | Q7Z5K2 | 832 |
| DSCC1 | ESCO2 | Q56NI9 | 826 |
| DSCC1 | PDS5A | Q29RF7 | 817 |
| DSCC1 | WDHD1 | O75717 | 773 |
| DSCC1 | ATAD5 | Q96QE3 | 736 |
| DSCC1 | RAD21 | O60216 | 715 |
| DSCC1 | TIPIN | Q9BVW5 | 588 |
IntAct
60 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RFXANK | RFXAP | psi-mi:“MI:0914”(association) | 0.780 |
| TAF12 | TAF4 | psi-mi:“MI:0914”(association) | 0.760 |
| RFC5 | RAD17 | psi-mi:“MI:0914”(association) | 0.730 |
| RFC4 | RAD17 | psi-mi:“MI:0914”(association) | 0.730 |
| DSCC1 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN1 | DSCC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC35G2 | DSCC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TAF8 | TAF4 | psi-mi:“MI:0914”(association) | 0.530 |
| DSCC1 | CHTF8 | psi-mi:“MI:0914”(association) | 0.530 |
| CDIPT | TTC5 | psi-mi:“MI:0914”(association) | 0.530 |
| CPNE5 | RAD21 | psi-mi:“MI:0914”(association) | 0.530 |
| PLPPR2 | METAP2 | psi-mi:“MI:0914”(association) | 0.530 |
| HMBOX1 | DPF2 | psi-mi:“MI:0914”(association) | 0.350 |
| P4HA2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| F9 | DDX11L8 | psi-mi:“MI:0914”(association) | 0.350 |
| CPNE5 | NCK2 | psi-mi:“MI:0914”(association) | 0.350 |
| RFC5 | RAD17 | psi-mi:“MI:0914”(association) | 0.350 |
| PLPPR2 | SEC24D | psi-mi:“MI:0914”(association) | 0.350 |
| SLC22A23 | BMP4 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (82): DSCC1 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), RFC4 (Affinity Capture-MS), RFC3 (Affinity Capture-MS), RFC5 (Affinity Capture-MS), RFC2 (Affinity Capture-MS), GTF2F1 (Affinity Capture-MS), CHTF18 (Affinity Capture-MS), BBS7 (Affinity Capture-MS), DSCC1 (Affinity Capture-MS), THOC1 (Co-fractionation), RFC3 (Affinity Capture-Western), DSCC1 (Affinity Capture-MS), RFC4 (Affinity Capture-MS), DSCC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1L8F8I9, A0A2R8QPS5, A1A5P5, A7S2N8, B0BM28, B4FGS2, B8AXB6, B8B624, B8JKF4, B9FM64, F1QNV4, F4IQJ2, P49842, P97564, Q08CY4, Q08DB2, Q0P5W1, Q0VA04, Q14AI0, Q2KI89, Q32PH0, Q3SYG4, Q3U0M1, Q4R804, Q5R629, Q61586, Q66I84, Q68F70, Q6DHG8, Q6GL75, Q6GMB0, Q6GN08, Q6GPP1, Q6NU25, Q6PA97, Q7T006, Q7XAM0, Q7Z3E5, Q811G0, Q8CIM8
Diamond homologs: Q14AI0, Q66I84, Q6GL75, Q6GMB0, Q9BVC3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 76 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Transcription of the HIV genome | 5 | 20.1× | 8e-04 |
| Regulation of TP53 Activity through Phosphorylation | 7 | 19.2× | 2e-05 |
| RNA Polymerase II Pre-transcription Events | 5 | 16.0× | 2e-03 |
| Transcriptional Regulation by TP53 | 6 | 8.7× | 4e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
62 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1227 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:119838254:CTTA:C | donor_gain | 1.0000 |
| 8:119838255:TTA:T | donor_loss | 1.0000 |
| 8:119838256:TAC:T | donor_loss | 1.0000 |
| 8:119838257:A:AC | donor_gain | 1.0000 |
| 8:119838257:ACTGA:A | donor_loss | 1.0000 |
| 8:119838258:C:CA | donor_gain | 1.0000 |
| 8:119838258:C:T | donor_loss | 1.0000 |
| 8:119838258:CT:C | donor_gain | 1.0000 |
| 8:119838258:CTG:C | donor_gain | 1.0000 |
| 8:119838258:CTGA:C | donor_gain | 1.0000 |
| 8:119838258:CTGAA:C | donor_gain | 1.0000 |
| 8:119838403:AAACC:A | acceptor_gain | 1.0000 |
| 8:119838404:AACC:A | acceptor_gain | 1.0000 |
| 8:119838405:ACC:A | acceptor_gain | 1.0000 |
| 8:119838406:CC:C | acceptor_gain | 1.0000 |
| 8:119838406:CCC:C | acceptor_gain | 1.0000 |
| 8:119838407:CC:C | acceptor_gain | 1.0000 |
| 8:119838408:C:CC | acceptor_gain | 1.0000 |
| 8:119838408:C:T | acceptor_gain | 1.0000 |
| 8:119838409:T:C | acceptor_loss | 1.0000 |
| 8:119838417:A:C | acceptor_gain | 1.0000 |
| 8:119841821:T:A | donor_gain | 1.0000 |
| 8:119841949:C:CC | acceptor_gain | 1.0000 |
| 8:119843603:ACTT:A | donor_loss | 1.0000 |
| 8:119843605:TTAC:T | donor_loss | 1.0000 |
| 8:119843606:TACTC:T | donor_loss | 1.0000 |
| 8:119843607:A:AC | donor_gain | 1.0000 |
| 8:119843607:ACT:A | donor_gain | 1.0000 |
| 8:119843608:C:CA | donor_gain | 1.0000 |
| 8:119843608:CT:C | donor_gain | 1.0000 |
AlphaMissense
2607 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:119843687:A:G | L213P | 0.985 |
| 8:119838290:A:G | W348R | 0.981 |
| 8:119838290:A:T | W348R | 0.981 |
| 8:119841854:A:C | F288L | 0.977 |
| 8:119841854:A:T | F288L | 0.977 |
| 8:119841856:A:G | F288L | 0.977 |
| 8:119847042:A:C | S175R | 0.977 |
| 8:119847042:A:T | S175R | 0.977 |
| 8:119847044:T:G | S175R | 0.977 |
| 8:119841844:A:G | W292R | 0.976 |
| 8:119841844:A:T | W292R | 0.976 |
| 8:119842808:A:G | L246P | 0.975 |
| 8:119843708:A:G | L206P | 0.974 |
| 8:119843654:A:T | V224D | 0.970 |
| 8:119853207:A:T | I64N | 0.970 |
| 8:119841869:G:C | F283L | 0.967 |
| 8:119841869:G:T | F283L | 0.967 |
| 8:119841871:A:G | F283L | 0.967 |
| 8:119853207:A:G | I64T | 0.967 |
| 8:119843705:A:G | L207P | 0.966 |
| 8:119841855:A:G | F288S | 0.963 |
| 8:119853207:A:C | I64S | 0.961 |
| 8:119847019:A:G | L183S | 0.959 |
| 8:119847064:A:G | L168S | 0.959 |
| 8:119838288:C:A | W348C | 0.958 |
| 8:119838288:C:G | W348C | 0.958 |
| 8:119843742:A:G | W195R | 0.958 |
| 8:119843742:A:T | W195R | 0.958 |
| 8:119841831:A:T | V296D | 0.957 |
| 8:119843640:A:G | C229R | 0.955 |
dbSNP variants (sampled 300 via entrez): RS1000130730 (8:119848469 A>G), RS1000147787 (8:119848906 C>T), RS1000188795 (8:119853332 C>T), RS1000410274 (8:119855874 C>A,G,T), RS1000715621 (8:119856097 T>C,G), RS1001161800 (8:119846672 C>T), RS1001387867 (8:119842163 T>A), RS1001663971 (8:119837846 G>A,C), RS1001714805 (8:119838359 G>A), RS1001956110 (8:119845936 G>A), RS1002053117 (8:119836270 A>G), RS1002298985 (8:119843342 C>T), RS1002452565 (8:119857740 A>C,G), RS1002591377 (8:119857507 C>T), RS1002704855 (8:119856818 G>A)
Disease associations
OMIM: gene MIM:613203 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004068_85 | Venous thromboembolism adjusted for sickle cell variant rs77121243-T | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
61 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| Benzo(a)pyrene | affects methylation, increases expression | 3 |
| Tetrachlorodibenzodioxin | affects expression, decreases expression | 3 |
| Cyclosporine | decreases expression | 3 |
| Aflatoxin B1 | affects expression, increases expression, increases methylation | 3 |
| Testosterone | affects cotreatment, decreases expression | 2 |
| Valproic Acid | affects cotreatment, increases expression, affects expression | 2 |
| GSK-J4 | decreases expression | 1 |
| afuresertib | decreases expression | 1 |
| lasiocarpine | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| 2,2’-methylenebis(4-methyl-6-tert-butylphenol) | affects expression, affects response to substance | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| pyrvinium | decreases reaction, increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | decreases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | decreases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| 7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one | decreases expression | 1 |
| NSC 689534 | decreases expression, affects binding | 1 |
| Atorvastatin | affects response to substance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.